Exome sequencing of 851 trios from more than 2,500 individuals finds 187 genes with de novo mutations that contribute to meningomyelocele (spina bifida) and highlights critical pathways required ...
The company’s shares rose by about 5% in early trading. Although small, the Phase 2 trial showed that a so-called exon-skipping therapy can result in “substantial improvements” in muscle health, Wave ...
ongoing evaluation of Tedopi® + OSE-279 in first-line HLA-A2 positive patients with NSCLC with PD-L1≥50%. Positive Phase 1/2 analysis of pegrizeprument (FR104/VEL-101) immunotherapy in kidney ...
SpecHLA reconstructs entire diploid sequences of HLA genes and infers LOH events. It supports HLA-A, -B, -C, -DPA1, -DPB1, -DQA1, -DQB1, and -DRB1 genes. Also, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback